- Home » News and EventsPage 27
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Collaborates with MGB Biopharma
Apr 25, 2019
SOMERSET, N.J. – April 25, 2019 — Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced t…
Technologies to Improve Patient Adherence and to be Discussed at CPhI NA
Apr 24, 2019
SOMERSET, N.J. – April 24, 2019 — Catalent (booth 1206), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, toda…
Catalent Invests $14 Million at its Eberbach, Germany Softgel Facility
Apr 23, 2019
Catalent Invests $14 Million at its Eberbach, Germany Softgel Facility. SOMERSET, N.J. – April 23, 2019 — Catalent, the leading global diversified provider of advanced delivery technologies and develo…
Patient-Centric Workshop to be Presented GCSG US
Apr 18, 2019
Catalent will also Discuss Direct-to-Patient Clinical Supplies, the Impact of Brexit on VAT Handling, and Japan’s Cultural and Regulatory Environment. SOMERSET, N.J. – April 18, 2019 — Catalent, a glo…
Catalent to acquire gene therapy leader Paragon Bioservices
Apr 15, 2019
Catalent to acquire gene therapy leader Paragon Bioservices. (NYSE: CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and …
Catalent Celebrates Opening of Second Shanghai Facility
Apr 11, 2019
SOMERSET, N.J. – April 11, 2019 — Catalent Pharma Solutions, a global leader in clinical supply services, today announced the completion of its new, 30,000-square-foot clinical supply facility in Shan…
Planning for Orphan Drug Supply to be Discussed
Apr 2, 2019
Planning for Orphan Drug Supply to be Discussed. SOMERSET, N.J. – April 2, 2019 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for…
Triphase Initiates Phase 1 Clinical Trial of B-cell Lymphoma Treatment
Apr 1, 2019
Triphase Initiates Phase 1 Clinical Trial of B-cell Lymphoma Treatment. Toronto, Ontario, and Somerset, N.J. – April 1, 2019 – Triphase Accelerator Corporation, a company dedicated to acquiring and de…
Catalent Biologics to Present at INTERPHEX
Mar 26, 2019
Catalent Biologics to Present at INTERPHEX. SOMERSET, N.J. – March 26, 2019 — Catalent Pharma Solutions (Booth 1145), the leading global provider of advanced delivery technologies and development solu…
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.